Session 3: Concept paper on key aspects for the use of pharmacogenomic methodologies… – Video




Session 3: Concept paper on key aspects for the use of pharmacogenomic methodologies...
...in the pharmacovigilance evaluation of medicinal products Session 3: Post-approval pharmacogenomics: impact on Risk Management Plans and Information Speaker: Qun-Ying Yue, CHMP-Pharmacogenomics Working Party and Pharmacovigilance Risk Assessment Committee member Workshop on Pharmacogenomics: from science to clinical care (8 October 2012)From:emainfoViews:0 0ratingsTime:23:17More inScience Technology

Read more:
Session 3: Concept paper on key aspects for the use of pharmacogenomic methodologies... - Video

Related Posts

Comments are closed.